These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11856351)

  • 1. Concentration-dependent reversible activation-inhibition of human butyrylcholinesterase by tetraethylammonium ion.
    Stojan J; Golicnik M; Froment MT; Estour F; Masson P
    Eur J Biochem; 2002 Feb; 269(4):1154-61. PubMed ID: 11856351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates.
    Masson P; Xie W; Froment MT; Levitsky V; Fortier PL; Albaret C; Lockridge O
    Biochim Biophys Acta; 1999 Aug; 1433(1-2):281-93. PubMed ID: 10446378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrylcholinesterase-catalyzed hydrolysis of N-methylindoxyl acetate: analysis of volume changes upon reaction and hysteretic behavior.
    Masson P; Froment MT; Fort S; Ribes F; Bec N; Balny C; Schopfer LM
    Biochim Biophys Acta; 2002 Jun; 1597(2):229-43. PubMed ID: 12044901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asp7O in the peripheral anionic site of human butyrylcholinesterase.
    Masson P; Froment MT; Bartels CF; Lockridge O
    Eur J Biochem; 1996 Jan; 235(1-2):36-48. PubMed ID: 8631355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyol-induced activation by excess substrate of the D70G butyrylcholinesterase mutant.
    Levitsky V; Xie W; Froment MT; Lockridge O; Masson P
    Biochim Biophys Acta; 1999 Jan; 1429(2):422-30. PubMed ID: 9989227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mutations of active site residues and amino acids interacting with the Omega loop on substrate activation of butyrylcholinesterase.
    Masson P; Xie W; Froment MT; Lockridge O
    Biochim Biophys Acta; 2001 Jan; 1544(1-2):166-76. PubMed ID: 11341926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters.
    Masson P; Froment MT; Fortier PL; Visicchio JE; Bartels CF; Lockridge O
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):41-52. PubMed ID: 9748494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Horse serum butyrylcholinesterase kinetics: a molecular mechanism based on inhibition studies with dansylaminoethyltrimethylammonium.
    Cauet G; Friboulet A; Thomas D
    Biochem Cell Biol; 1987 Jun; 65(6):529-35. PubMed ID: 3426832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.
    Masson P; Froment MT; Gillon E; Nachon F; Lockridge O; Schopfer LM
    FEBS J; 2008 May; 275(10):2617-31. PubMed ID: 18422653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine. Volumetric study of wild-type and D70G mutant behavior.
    Masson P; Bec N; Froment MT; Nachon F; Balny C; Lockridge O; Schopfer LM
    Eur J Biochem; 2004 May; 271(10):1980-90. PubMed ID: 15128307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
    Loewenstein Y; Gnatt A; Neville LF; Soreq H
    J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphobutyrylcholinesterase: phosphorylation of the esteratic site of butyrylcholinesterase by ethephon [(2-chloroethyl)phosphonic acid] dianion.
    Haux JE; Quistad GB; Casida JE
    Chem Res Toxicol; 2000 Jul; 13(7):646-51. PubMed ID: 10898597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides.
    Masson P; Froment MT; Gillon E; Nachon F; Darvesh S; Schopfer LM
    Biochim Biophys Acta; 2007 Sep; 1774(9):1139-47. PubMed ID: 17690023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the peripheral site of human butyrylcholinesterase.
    Macdonald IR; Martin E; Rosenberry TL; Darvesh S
    Biochemistry; 2012 Sep; 51(36):7046-53. PubMed ID: 22901043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic model of ethopropazine interaction with horse serum butyrylcholinesterase and its docking into the active site.
    Golicnik M; Sinko G; Simeon-Rudolf V; Grubic Z; Stojan J
    Arch Biochem Biophys; 2002 Feb; 398(1):23-31. PubMed ID: 11811945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High activity of human butyrylcholinesterase at low pH in the presence of excess butyrylthiocholine.
    Masson P; Nachon F; Bartels CF; Froment MT; Ribes F; Matthews C; Lockridge O
    Eur J Biochem; 2003 Jan; 270(2):315-24. PubMed ID: 12605682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.
    Masson P; Froment MT; Bartels CF; Lockridge O
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):53-61. PubMed ID: 9224629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
    Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
    J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprophen: a substrate and inhibitor of butyrylcholinesterase and carboxylesterases.
    Rush RS; Ralston JS; Wolfe AD
    Biochem Pharmacol; 1985 Jun; 34(12):2063-8. PubMed ID: 4004924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.